Acute and chronic effects of caffeine on performance, mood, headache, and sleep

Neuropsychobiology

Volumn 38, Issue 1, 1998, Pages 32-41

  James, Jack E ^a,b  

^a LA TROBE UNIVERSITY   (Australia)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Caffeine; Caffeine tolerance; Caffeine withdrawal; Coffee; Headache; Mood; Performance; Sleep

Indexed keywords

CAFFEINE; PLACEBO; PSYCHOTROPIC AGENT;

ALERTNESS; ARTICLE; CLINICAL TRIAL; COFFEE; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HABITUATION; HEADACHE; HUMAN; HUMAN EXPERIMENT; INGESTION; MALE; MOOD; NORMAL HUMAN; PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP TIME;

ACUTE DISEASE; AFFECT; ANALYSIS OF VARIANCE; CAFFEINE; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CROSS-OVER STUDIES; FEMALE; HEADACHE; HUMANS; MALE; MEMORY; MODELS, PSYCHOLOGICAL; PSYCHOMOTOR PERFORMANCE; REFERENCE VALUES; SALIVA; SEX DISTRIBUTION; SLEEP; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0031855284     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026514     Document Type: Article

References (46)

1. Gilbert RM: Caffeine consumption; in Spiller GA (ed): The Methylxanthine Beverages and Foods. Chem Consumption and Health Effects. New York, Liss, 1984, pp 185-214.
2. James JE: Understanding Caffeine. A Biobehavioral Analysis. Thousand Oaks, Sage, 1997.
3. Wharrad JJ, Birmingham AT, MacDonald IA, Inch PJ, Mead JL: The influence of fasting and of caffeine intake on finger tremor. Eur J Clin Pharmacol 1985;29:37-43.
4. Chait LD, Griffiths RR: Effects of caffeine on cigarette smoking and subjective response. Clin Pharmacol Ther 1983;34:612-622.
5. James JE: The influence of user status and anxious disposition on the hypertensive effects of caffeine. Int J Psychophysiol 1990;10:171-179.
6. Richardson NJ, Rogers PJ, Elliman NA, O'Dell RJ: Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol Biochem Behav 1995;52: 313-320.
7. Dews PB: Behavioral effects of caffeine; in Dews PB (ed): Caffeine: Perspectives from Recent Research. Berlin, Springer, 1984, pp 86-103.
8. Stavric B: Methylxanthines: Toxicity to humans. 2. Caffeine. Food Chem Toxicol 1988; 26:645-662.
9. James JE: Caffeine and Health. London, Academic Press, 1991.
10. Heishman SJ, Snyder FR, Henningfield JE: Performance, subjective and physiological effects of nicotine in non-smokers. Drug Alcohol Depend 1993;34:11-18.
11. Hughes JR: Distinguishing withdrawal relief and direct effects of smoking. Psychopharmacology 1991;104:409-410.
12. James JE: Does caffeine enhance or merely restore degraded psychomotor performance? Neuropsychobiology 1994;30:124-125.
13. Smith A: Caffeine and psychomotor performance: A replay to James (letter). Addiction 1995;90:1261-1265.
14. James JE: Caffeine and psychomotor performance revisited. Neuropsychobiology 1995;31: 202-203.
15. Warburton DM: Effects of caffeine on cognition and mood without caffeine abstinence. Psychopharmacology 1995;119:66-70.
16. James JE: Psychophysiological effects of habitual caffeine consumption. Int J Behav Med 1994;1:247-263.
17. James JE: Chronic effects of habitual caffeine consumption on laboratory and ambulatory blood pressure levels. J Cardiovasc Res 1994;1: 159-164.
18. James JE: Is habitual caffeine use a preventable cardiovascular risk factor? Lancet 1997;349: 279-281.
19. Griffiths RR, Mumford GK: Caffeine reinforcement discrimination tolerance and physical dependence in laboratory animals and humans; in Schuster CR, Gust SW, Kuhar MJ (eds): Pharmacological Aspects of Drug Dependence. Toward an Integrated Neurobehavioral Approach. Handbook of Experimental Pharmacology. New York, Springer, 1995.
20. Silverman K, Evans SM, Strain EC, Griffiths RR: Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992;327:1109-1114.
21. James JE, Bruce MS, Lader MH, Scott NR: Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol 1989;27:507-514.
22. Parsons WD, Neims MD: Effect of smoking on caffeine clearance. Clin Pharmacol Ther 1978; 24:40-45.
23. Abernethy DR, Todd EL: Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 1985;28:425-428.
24. Pfeifer RW, Notari RE: Predicting caffeine plasma concentrations resulting from consumption of food or beverages: A simple method and its origin. Drug Intell Clin Pharm 1988; 22:953-959.
25. Robertson D, Wade D, Workman R, Woosley RL, Oates JA: Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 1981;67:1111-1117.
26. Denaro C, Brown CR, Jacob P III, Benowitz NL: Effects of caffeine with repeated dosing. Eur J Clin Pharmacol 1991;403:273-278.
27. Alkaysi HN, Shiekh Salem M, El-Sayed YM: High performance liquid chromatographic analysis of caffeine concentrations in plasma and saliva. J Clin Pharmacol 1988;13:109-115.
28. Lelo A, Miners JO, Robson R, Birkett DJ: Assessment of caffeine exposure: Caffeine content of beverages: Caffeine intake and plasma concentrations of methylxanthines. Clin Pharmacol Ther 1986;39:54-59.
29. Badcock NR: Simpler measurement of caffeine and paraxanthine in saliva. Clin Chem 1989; 36:391.
30. Humphreys MS, Revelle W: Personality motivation and performance: A theory of the relationship between individual differences and information processing. Psychol Rev 1984;91: 153-184.
31. McNair PM, Lorr M, Droppleman LF: Profile of Mood States Manual. San Diego, Educational and Industrial Testing Service, 1971.
32. Lieberman HR, Corkin S, Spring BJ, Growdon JH, Wurtman RJ: Mood performance and pain sensitivity: Changes induced by food constituents. J Psychiatr Res 1983;17:135-145.
33. Vasey MW, Thayer JF: The continuing problem of false positives in repeated measures of ANOVA in psychophysiology: A multivariate solution. Psychophysiology 1987;24:479-486.
34. Cameron OG, Modell JG, Hariharan M: Caffeine and human cerebral blood flow: A positron emission tomography study. Life Sci 1990; 47:1141-1146.
35. Mathew RJ, Wilson WH: Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders. Acta Psychiatr Scand 1990; 821:17-22.
36. Hughes JR, Higgins ST, Bickel WK, Hunt WK, Fenwick JW, Gulliver SB, Mireault GC: Caffeine self-administration withdrawal and adverse effects among coffee drinkers. Arch Gen Psychiatry 1991;48:611-617.
37. van Dusseldorp M, Katan MB: Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: A 12 week double blind trial. BMJ 1990;300:1558-1559.
38. Griffiths RR, Evans SM, Heishman SJ, Preston KL, Sannerud CA, Wolf B, Woodson PP: Low-dose caffeine physical dependence in humans. J Pharmacol Exp Ther 1990;255:1123-1132.
39. Lieberman HR, Wurtman RJ, Emde GG, Roberts C, Coviella ILG: The effects of low doses of caffeine on human performance and mood. Psychopharmacology 1987;92:308-312.
40. Smith A, Kendrick AM, Maben AL, Salmon J: Effects of breakfast and caffeine on cognitive performance mood and cardiovascular functioning. Appetite 1994;221:39-55.
41. King DJ, Henry G: The effect of neuroleptics on cognitive and psychomotor function. A preliminary study in healthy volunteers. Br J Psychiatry 1992;160:647-653.
42. Rush CR, Higgins ST, Bickel WK, Hughes JR: Acute behavioral effects of lorazepam and caffeine alone and in combination in humans. Behav Pharmacol 1994;5:245-254.
43. Goldstein AR, Warren R, Kaizer S: Psychotropic effects of caffeine in man. I. Individual differences in sensitivity to caffeine induced wakefulness. J Pharmacol Exp Ther 1965;149: 156-159.
44. Goldstein AS, Kaizer S, Whitby O: Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther 1969;10:489-497.
45. Penetar D, McCann U, Throne D, Kamimori G, Galinski C, Sing H, Thomas M, Belenky G: Caffeine reversal of sleep deprivation effects on alertness and mood. Psychopharmacology 1993;1122-3:359-365.
46. Rosenthal L, Roehrs T, Zwyghuizen-Doorenbos A, Plath D, Roth T: Alerting effects of caffeine after normal and restricted sleep. Neuropsychopharmacology 1991;42:103-108.